Mankind Ceftiforce-Tazo Pet Injection 562.5 mg

Mankind Ceftiforce-Tazo Pet Injection 562.5 mg is a veterinary injectable formulation containing ceftriaxone 500 mg and tazobactam 62.5 mg per vial. The brochure specifies a 562.5 mg pack supplied with a syringe and needle.

Composition per vial

• Ceftriaxone: 500 mg
• Tazobactam: 62.5 mg
• Total combined strength: 562.5 mg

Veterinary indications

The supplied product brochure lists bone and joint infections, bacterial meningitis, intra-abdominal infections, urinary tract infections, bacterial septicemia, and skin and soft-tissue infections. A veterinarian must assess the animal and determine whether this medicine is appropriate.

Administration and precautions

For administration by a veterinarian through the intramuscular or intravenous route, as directed. The treating veterinarian must determine the dose, preparation, frequency and treatment duration. Do not self-administer. Follow the product label and leaflet for reconstitution, handling and storage.

Pack and manufacturing details

Available pack: 562.5 mg with syringe and needle. The brochure identifies a USP Type I vial and describes the manufacturing unit as WHO-GMP compliant. This manufacturing statement is not a claim of separate product certification.